nach oben

ADHD Attention Deficit and Hyperactivity Disorders

Erschienen in:

01.12.2013 | Original Article

Adults with ADHD: use and misuse of stimulant medication as reported by patients and their primary care physicians

verfasst von: Michael B. Lensing, Pål Zeiner, Leiv Sandvik, Stein Opjordsmoen

Erschienen in: ADHD Attention Deficit and Hyperactivity Disorders | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

This study investigated the agreement on treatment for attention-deficit/hyperactivity disorder (ADHD) between adults with ADHD and the primary care physicians responsible for their treatment. Adults with ADHD and the primary care physicians responsible for their ADHD treatment completed a survey. The κ-statistic assessed physician–patient agreement on ADHD treatment variables. The eligible sample consisted of 274 patients with confirmed current or previous psychopharmacological treatment for ADHD and the physicians responsible for their treatment. We received 159 questionnaires (58.0 %) with sufficient information from both sources. There were no significant differences between participants and nonparticipants (N = 115) on ADHD sample characteristics. Participants’ mean age was 37.6 years, and 75 (47.2 %) were females. There was high agreement for current pharmacological treatment for ADHD, current and last ADHD drug prescription, treatment for substance use, and misuse of stimulant medication. Agreement for nonpharmacological treatment for ADHD and treatment termination because of the side effects was low. A minority of participants from both sources reported misuse of stimulant medication. There was a moderate correlation between the physicians’ clinical judgment and patients’ self-report on current functioning. The study showed that primary care physicians and their patients agreed on the pharmacological but not the nonpharmacological, treatments given. They also agreed on patients’ current functioning. Physicians and patients reported low levels of misuse of stimulant medication. The results show that pharmacological treatment for adults with ADHD can be safely undertaken by primary care physicians.

Adams JR, Drake RE (2006) Shared decision-making and evidence-based practice. Community Ment Health J 42(1):87–105PubMedCrossRef

Adler L, Shaw D, Sitt D, Maya E, Morrill I (2009) Issues in the diagnosis and treatment of adult ADHD by primary care physicians. Primary Psychiatry 16(5):57–63

American Psychiatric Association (APA) (2000) Diagnostic and statistical manual of mental disorders text revision, 4th edn. American Psychiatric Association, Washington

Barkley RA, Fischer M, Smallish L, Fletcher K (2006) Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry 45(2):192–202PubMedCrossRef

Biederman J, Faraone SV (2005) Attention-deficit hyperactivity disorder. Lancet 366(9481):237–248PubMedCrossRef

Biederman J, Petty CR, Woodworth KY, Lomedico A, Hyder LL, Faraone SV (2012) Adult outcome of attention-deficit/hyperactivity disorder: a controlled 16-year follow-up study. J Clin Psychiatry 73(7):941–950PubMedCrossRef

Braddock CH III, Edwards KA, Hasenberg NM, Laidley TL, Levinson W (1999) Informed decision making in outpatient practice: time to get back to basics. JAMA 282(24):2313–2320PubMedCrossRef

Brinkman WB, Hartl J, Rawe LM, Sucharew H, Britto MT, Epstein JN (2011) Physicians’ shared decision-making behaviors in attention-deficit/hyperactivity disorder care. Arch Pediatr Adolesc Med 165(11):1013–1019PubMedCrossRef

Cooper-Patrick L, Gallo JJ, Gonzales JJ, Vu HT, Powe NR, Nelson C, Ford DE (1999) Race, gender, and partnership in the patient-physician relationship. JAMA 282(6):583–589PubMedCrossRef

Deber RB (1994) Physicians in health care management: 8. The patient-physician partnership: decision making, problem solving and the desire to participate. CMAJ 151(4):423–427PubMed

Elia J, Ambrosini PJ, Rapoport JL (1999) Treatment of attention-deficit-hyperactivity disorder. N Engl J Med 340(10):780–788PubMedCrossRef

Fiks AG, Hughes CC, Gafen A, Guevara JP, Barg FK (2011) Contrasting parents’ and pediatricians’ perspectives on shared decision-making in ADHD. Pediatrics 127(1):e188–e196PubMedCrossRef

Goodman DW, Surman CB, Scherer PB, Salinas GD, Brown JJ (2012) Assessment of physician practices in adult attention-deficit/hyperactivity disorder. Prim Care Companion CNS Disord 14(4). pii: PCC11m01312. doi:10.4088/PCC.11m01312

Goss C, Moretti F, Mazzi MA, Del PL, Rimondini M, Zimmermann C (2008) Involving patients in decisions during psychiatric consultations. Br J Psychiatry 193(5):416–421PubMedCrossRef

Hamann J, Leucht S, Kissling W (2003) Shared decision making in psychiatry. Acta Psychiatr Scand 107(6):403–409PubMedCrossRef

Hinnenthal JA, Perwien AR, Sterling KL (2005) A comparison of service use and costs among adults with ADHD and adults with other chronic diseases. Psychiatr Serv 56(12):1593–1599PubMedCrossRef

Hinshaw SP, Scheffler RM, Fulton BD, Aase H, Banaschewski T, Cheng W, Mattos P, Holte A, Levy F, Sadeh A, Sergeant JA, Taylor E, Weiss MD (2011) International variation in treatment procedures for ADHD: social context and recent trends. Psychiatr Serv 62(5):459–464PubMedCrossRef

Hodgkins P, Montejano L, Sasane R, Huse D (2011) Cost of illness and comorbidities in adults diagnosed with attention-deficit/hyperactivity disorder: a retrospective analysis. Prim Care Companion CNS Disord 13(2):e1–e12

Hooper R, Rona RJ, French C, Jones M, Wessely S (2005) Unmet expectations in primary care and the agreement between doctor and patient: a questionnaire study. Health Expect 8(1):26–33PubMedCrossRef

Kaplan SH, Greenfield S, Ware JE Jr (1989) Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Med Care 27(3 Suppl):S110–S127PubMedCrossRef

Kaye S, Darke S (2012) The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care? Addiction 107(3):467–477PubMedCrossRef

Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, Howes MJ, Jin R, Secnik K, Spencer T, Ustun TB, Walters EE (2005) The World Health Organization adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med 35(2):245–256PubMedCrossRef

Kirkwood BR, Sterne JSC (2011) Essential medical statistics Malden, Massachusetts 02148-5020. Blackwell Science Ltd, USA

Klein RG, Mannuzza S, Olazagasti MA, Roizen E, Hutchison JA, Lashua EC, Castellanos FX (2012) Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later. Arch Gen Psychiatry 69(12):1295–1303

Kovshoff H, Vrijens M, Thompson M, Yardley L, Hodgkins P, Sonuga-Barke EJ, Danckaerts M (2013) What influences clinicians’ decisions about ADHD medication? Initial data from the Influences on Prescribing for ADHD Questionnaire (IPAQ). Eur Child Adolesc Psychiatry [Epub ahead of print]

Kraemer M, Uekermann J, Wiltfang J, Kis B (2010) Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature. Clin Neuropharmacol 33(4):204–206PubMedCrossRef

Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174PubMedCrossRef

Lensing MB, Zeiner P, Sandvik L, Opjordsmoen S (2013) Four-year outcome in psychopharmacologically treated adults with ADHD. J Clin Psychiatry 74(1):e87–e93PubMedCrossRef

Leon AC, Olfson M, Portera L, Farber L, Sheehan DV (1997) Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. Int J Psychiatry Med 27(2):93–105PubMedCrossRef

McCarthy S, Wilton L, Murray M, Hodgkins P, Asherson P, Wong IC (2013) Management of adult attention deficit hyperactivity disorder in UK primary care: a survey of general practitioners. Health Qual Life Outcomes 11(1):22PubMedCrossRef

Michielsen M, Semeijn E, Comijs HC, van d, V, Beekman AT, Deeg DJ, Kooij JJ (2012) Prevalence of attention-deficit hyperactivity disorder in older adults in The Netherlands. Br J Psychiatry:201(4):298–305

Mongia M, Hechtman L (2012) Cognitive behavior therapy for adults with attention-deficit/hyperactivity disorder: a review of recent randomized controlled trials. Curr Psychiatry Rep 14(5):561–567PubMedCrossRef

National Institute for Health and Clinical Excellence (2008) Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults. Clinical guideline 72. Available at www.nice.org.uk/CG72

Rafalovich A (2005) Exploring clinician uncertainty in the diagnosis and treatment of attention deficit hyperactivity disorder. Sociol Health Illn 27(3):305–323PubMedCrossRef

Rohrbaugh M, Rogers JC (1994) What did the doctor do? When physicians and patients disagree. Arch Fam Med 3(2):125–128PubMedCrossRef

Safren SA (2006) Cognitive-behavioral approaches to ADHD treatment in adulthood. J Clin Psychiatry 67(Suppl):846–850

Shaw K, Wagner I, Eastwood H, Mitchell G (2003) A qualitative study of Australian GPs’ attitudes and practices in the diagnosis and management of attention-deficit/hyperactivity disorder (ADHD). Fam Pract 20(2):129–134PubMedCrossRef

Simon V, Czobor P, Balint S, Meszaros A, Bitter I (2009) Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry 194(3):204–211PubMedCrossRef

Sobanski E, Bruggemann D, Alm B, Kern S, Deschner M, Schubert T, Philipsen A, Rietschel M (2007) Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci 257(7):371–377PubMedCrossRef

Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJ, Jensen PS, Cantwell DP (1998) Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 351(9100):429–433PubMedCrossRef

Taylor E, Dopfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga-Barke E, Steinhausen HC, Zuddas A (2004) European clinical guidelines for hyperkinetic disorder—first upgrade. Eur Child Adolesc Psychiatry 13 Suppl:117–130

Taylor A, Deb S, Unwin G (2011) Scales for the identification of adults with attention deficit hyperactivity disorder (ADHD): a systematic review. Res Dev Disabil 32(3):924–938PubMedCrossRef

Thapar A, Thapar A (2002) Is primary care ready to take on attention deficit hyperactivity disorder? BMC Fam Pract 3:7

The Norwegian Directorate of Health (2007) National guidelines for diagnosis and treatment of AD/HD (IS-1244 Veileder i diagnostikk og behandling av AD/HD) Oslo, Helsedirektoratet

Torgersen T, Gjervan B, Rasmussen K, Vaaler A, Nordahl HM (2013) Prevalence of comorbid substance use disorder during long-term central stimulant treatment in adult ADHD. Atten Defic Hyperact Disord 5(1):59–67PubMedCrossRef

Turgay A, Goodman DW, Asherson P, Lasser RA, Babcock TF, Pucci ML, Barkley R (2012) Lifespan persistence of ADHD: the life transition model and its application. J Clin Psychiatry 73(2):192–201PubMedCrossRef

Waitzkin H (1984) Doctor–patient communication. Clinical implications of social scientific research. JAMA 252(17):2441–2446PubMedCrossRef

Titel: Adults with ADHD: use and misuse of stimulant medication as reported by patients and their primary care physicians
verfasst von: Michael B. Lensing
Pål Zeiner
Leiv Sandvik
Stein Opjordsmoen
Publikationsdatum: 01.12.2013
Verlag: Springer Vienna
Erschienen in: ADHD Attention Deficit and Hyperactivity Disorders / Ausgabe 4/2013
Print ISSN: 1866-6116
Elektronische ISSN: 1866-6647
DOI: https://doi.org/10.1007/s12402-013-0116-8

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2013

Comorbidity and continuity of attention deficit hyperactivity disorder (ADHD) from childhood to adolescence in Turkey

Atomoxetine response in the inattentive and combined subtypes of attention deficit hyperactivity disorder: a retrospective chart review

Self-regulation strategies support children with ADHD to overcome symptom-related behavior in the classroom

A non-interventional study of extended-release methylphenidate in the routine treatment of adolescents with ADHD: effectiveness, safety and adherence to treatment

Verbal fluency in adults diagnosed with attention-deficit hyperactivity disorder (ADHD) in childhood